associate sponsors


Dr Reddy's launches generic Lamotrigine tablets in US

New Delhi: Pharmaceutical major Dr Reddy's Laboratories Monday said it has launched generic Lamotrigine orally disintegrating tablets used for treatment of certain types of seizures in epileptic patients in the US market.

The company's tablets are in the strengths of 25 mg, 50 mg, 100 mg and 200 mg, Dr Reddy's Laboratories said in a filing to BSE.


The company's product is generic version of GSK Group of companies' Lamictal tablets, it added.

"The Lamictal ODT brand and generic had US sales of approximately $65.5 million MAT for the most recent twelve months ending July 2016 according to IMS Health," Dr Reddy's Laboratories said.

Lamictal is indicated as adjunctive therapy for the certain type of seizures and for the maintenance treatment of bipolar disorder.

Updated Date: Oct 10, 2016 18:47 PM

Also Watch

Social Media Star: Abhishek Bachchan, Varun Grover reveal how they handle selfies, trolls and broccoli
  • Monday, July 16, 2018 It's a Wrap: Soorma star Diljit Dosanjh and Hockey legend Sandeep Singh in conversation with Parul Sharma
  • Monday, July 16, 2018 Watch: Dalit man in Uttar Pradesh defies decades of prejudice by taking out baraat in Thakur-dominated Nizampur village
  • Monday, July 16, 2018 India's water crisis: After govt apathy, Odisha farmer carves out 3-km canal from hills to tackle scarcity in village
  • Sunday, July 15, 2018 Maurizio Sarri, named as new Chelsea manager, is owner Roman Abramovich's latest gamble in quest for 'perfect football'

Also See